Radiopharmaceuticals Market Size, Share & Trends Analysis Report by Type (Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other, PET Radiopharmaceuticals, F-18, RU-82, Others, Therapeutic Nuclear Medicine, Alpha Emitters, Ra-223, Brachytherapy Isotopes, Intoiodine-125, Palladium-103, Cesium-131, Iridium-192, Other brachytherapy isotopes, Beta Emitters, Intoiodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other beta emitters) by Application (Diagnostic Applications, SPECT Applications, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications, PET applications, Oncology, Cardiology, Neurology, Other PET applications, Therapeutic Applications, Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications) by Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures, Source) by Source (Nuclear Reactors, Cyclotrons) by End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2017 - 2022) & Forecast (2023 - 2030)

Billing Address

Choose Your Payment Method

Selected Plan

Standard License

$ 4299


  • Report accessible by 1 user only
  • Free 15% or 20 hours of customisation
  • Free post-sale service assistance
  • Direct access to lead analysts on mail
  • Report delivery on PDF & Excel
  • Report Coverage: Global
  • Free Post-Sale Service Assistance